Alacris Theranostics

Alacris Theranostics

Alacris Theranostics GmbH
Fabeckstrasse 60-62
14195 Berlin
www.alacris.de

Participant's Lead

Dr Bodo Lange

Dr Bodo Lange
Phone +49 30 84131645
Contact

Institute Presentation

Alacris Theranostics uses next generation sequencing technologies coupled with computational modeling of tumor and somatic tissues in order to indentify individualised therapies for cancer patients. The company also uses these technologies to help pharmaceutical partners stratify patients for their clinical trials. Alacris has an exclusive worldwide commercial license for the computational modeling of tumors and somatic tissues using proprietary computational systems modeling technologies ModCell™ developed at the Max Planck Institute for Molecular Genetics (MPI-MG) in Berlin coupled with next generation sequencing and genotyping technology developed at Harvard Medical School in Boston.